MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SANDERS, E.
Right arrow Articles by MAREN, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SANDERS, E.
Right arrow Articles by MAREN, T. H.

Molecular Pharmacology, Vol 3, 204-215, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of Carbonic Anhydrase in Neisseria: Effects on Enzyme Activity and Growth

EUGENE SANDERS 1 and THOMAS H. MAREN 1

1 Departments of Medicine, Microbiology, and Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, Florida 32601

The presence of carbonic anhydrase in strains of Neisseria has been detected and quantified. Each of ten sulfonamide carbonic anhydrase inhibitors tested antagonized activity of bacterial carbonic anhydrase. Nine of these inhibited growth of carbonic anhydrase-producing strains of Neisseria. The more active drugs inhibited growth in concentrations as low as 0.005 µg/ml. Organisms lacking carbonic anhydrase were unaffected. Carbon dioxide markedly limited the antibacterial activity of these drugs. p-Aminobenzoate had no effect on their activity. It is concluded that bicarbonate is a growth requirement for strains of Neisseria that contain carbonic anhydrase, and that the mechanism of antibacterial activity of these drugs is reduction in the rate of bicarbonate formation.

Note:
ACKNOWLEDGMENTS The authors wish to acknowledge their indebtedness to Miss Christine Wiley, Mrs. Aija Gotti, Miss Sandra MacKay, and Miss Linda Joslyn for technical assistance. This work was supported in part by National Institutes of Health Research Grants NBO1297 and A106514-01.

Submitted on November 28, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics